Siemens has built a synchronous machine consisting of an HTS rotor and an air-cored stator. Rotor cooling is provided by a Gifford-McMahon (GM) "off the shelf" cryocooler, the typical requirement being about 30 W @ 25 K. The machine was designed for a rated power of 380 kW (rated voltage 3 phases 400 V Y), but achieved a maximum continuous power of 450 kW and a short term maximum power of 590 kW at 1500 rpm. In all cases, output power was limited by stator cooling. Characteristic parameters such as reactances, inductances, and time constants were determined to obtain a consistent overview of the machine properties. The machine was tested under different operational modes, including motor mode as well as generator mode. In the generator mode, it was operated on water cooled resistors or connected to the grid. The properties of motor mode have been determined synchronized to the grid as well as via an inverter. Special attention was taken to investigate the influences of asymmetric loads, grid and inverter harmonics on rotor cooling requirements. Numerical calculations were performed and compared to the experimental data showing good correlation.
We report on the successful manufacture and testing of the Siemens 400 kVA HTS synchronous motor, which has been in operation for over 3 years, and on the progress of the 4 MVA synchronous motor/generator, which has been manufactured and is now in a phase of extended testing. Furthermore, the benefits of HTS machines will be discussed with emphasis on applications in ships. The development of future marketable products will be strongly dependent on the progress of secondary technologies, such as wire performance and efficient cost-effective refrigerators.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.